Homologous Ad26.COV2.S vaccination results in reduced boosting of humoral responses in hybrid immunity, but elicits antibodies of similar magnitude regardless of prior infection

Mostrar otras versiones (1)

The impact of previous SARS-CoV-2 infection on the durability of Ad26.COV2.S vaccine-elicited responses, and the effect of homologous boosting has not been well explored. We followed a cohort of healthcare workers for 6 months after receiving the Ad26.COV2.S vaccine and a further one month after the...

Descripción completa

Detalles Bibliográficos
Autores principales: Moyo-Gwete, Thandeka, Richardson, Simone I., Keeton, Roanne, Hermanus, Tandile, Spencer, Holly, Manamela, Nelia P., Ayres, Frances, Makhado, Zanele, Motlou, Thopisang, Tincho, Marius B., Benede, Ntombi, Ngomti, Amkele, Baguma, Richard, Chauke, Masego V., Mennen, Mathilda, Adriaanse, Marguerite, Skelem, Sango, Goga, Ameena, Garrett, Nigel, Bekker, Linda-Gail, Gray, Glenda, Ntusi, Ntobeko A. B., Riou, Catherine, Burgers, Wendy A., Moore, Penny L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10684107/
https://www.ncbi.nlm.nih.gov/pubmed/37943890
http://dx.doi.org/10.1371/journal.ppat.1011772

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10684107/
https://www.ncbi.nlm.nih.gov/pubmed/37943890
http://dx.doi.org/10.1371/journal.ppat.1011772

Ejemplares similares